{
  "report_rows": [
    {
      "kpi": "2Q26 net sales",
      "prediction": "BEAT",
      "answer": "pred ~$3.96B vs. cons $3.91B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$342M vs. cons $334M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.36 vs. cons $1.29",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 net sales guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$14.6B-$15.6B vs. cons $14.9B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.10B-$1.50B vs. cons $1.30B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted EBITDA margin guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.5%-9.6% vs. cons 8.6% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 5.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.5,
  "day5_path": "FADE",
  "day5_rationale": "A ~$342M 2Q EBITDA result versus ~$334M consensus and maintained ~$1.10B-$1.50B FY26 EBITDA guidance versus ~$1.30B consensus should initially validate margin stabilization, but the unchanged guide still embeds only ~$1.30B midpoint FY EBITDA and leaves ~$744M of implied 2H EBITDA after the ~$556M first half, limiting upward out-period revisions.",
  "day5_confidence": "MEDIUM"
}